Gastrointestinal stromal tumors (GISTs) are a rare type of cancer that develops in the digestive tract. While they usually occur in the stomach, they can also occur in the small intestine. They arise from special cells in the wall of the digestive tract, known as interstitial cells of Cajal (ICCs). These cells act as “pacemakers” that control the movement of food through the gut by regulating muscle contractions.
GISTs can range from very small, slow-growing tumors to larger, aggressive cancers that spread to other organs. The primary cause of GISTs is genetic mutations in specific genes that control cell growth.
Different types of gene mutations include:
- KIT gene mutation: It is found in about 75-80% cases. This mutation makes the KIT protein (a receptor tyrosine kinase) constantly active. This leads to uncontrolled cell growth.
- PDGFRA gene mutation: It is found in about 5-10% cases. Like KIT, PDGFRA mutations constantly produce signals for cell division.
- Other rare mutations: Some mutations involve genes like SDH, BRAF, or NF1.
Most GISTs are not inherited; they occur due to random mutations in cells. However, rare familial cases exist. These mutations lead to constant activation of tyrosine kinase receptors. As a result, the overgrowth of cells forms a mass in the stomach or intestine, which can be cancerous over time. Detecting these proteins is critical for diagnosis and research. Here is where polyclonal antibodies (pAbs) come into play.
What are Polyclonal Antibodies?
Polyclonal antibodies are a collection of antibodies produced by different immune cells (B-cells) in the body in response to a single antigen (a foreign substance such as a protein, virus, or bacteria).
When an antigen enters the body, it usually has many different epitopes (specific sites on its surface). Each B-cell produces an antibody that recognizes just one epitope. Since many B-cells respond at once, the result is a mixture of antibodies that can bind to multiple sites on the same antigen. This mixture is called polyclonal antibodies.
In GISTs, researchers use polyclonal antibodies (pAbs) to find proteins made at different levels. They also use them to confirm mutations and study the signals that make tumors grow.
For example:
Scientists use the rabbit cyclin B1 polyclonal antibody to study cell cycle changes in GISTs. Cyclin B1 controls the shift from the G2 phase to mitosis in cell division. When tumor cells make too much Cyclin B1, they skip normal checks. This leads to uncontrolled growth.
Because pAbs attach to many parts of a protein, Scientists can spot this extra Cyclin B1 and link it to tumor growth. This further helps study cancers like GISTs.
Role of pAbs in GISTs Research
1. Detect Key Tumor Markers
GISTs make certain proteins that act as “markers.” These include KIT (CD117) and DOG1. During GISTs, the levels of these markers are much higher than the levels in normal tissues.
At times, researchers use polyclonal antibodies to look for these proteins in tumor samples. They place the sample on a slide and add the antibody. If the protein is present, the antibody sticks to it. When viewed under a microscope, the protein becomes visible because it “lights up” after staining. This method helps confirm that the tumor is truly a GIST and not another type of digestive tract cancer.
2. Confirm Gene Mutations
Most GISTs have mutations in the KIT or PDGFRA genes. These mutations change the structure of their proteins, making them always active.
Polyclonal antibodies can attach to these altered proteins. When researchers see these abnormal proteins in tumor cells, they know a mutation is present.
This is important because the type of mutation can guide treatment. For example, some patients respond well to tyrosine kinase inhibitors (TKIs) like imatinib, while others do not. pAbs help researchers make these treatment decisions more accurate.
3. Study Cell Cycle Abnormalities
Cells grow and divide in a cycle. Proteins control when a cell should move from one stage to the next. One such protein is Cyclin B1.
In GISTs, tumor cells often make too much Cyclin B1. This makes them divide too quickly.
Scientists use rabbit Cyclin B1 polyclonal antibodies to measure Cyclin B1 levels. If the protein is high, it shows that the tumor is growing aggressively. This helps explain why some GISTs spread faster than others.
4. Map Signaling Pathways
Tumor growth in GISTs depends on faulty “signaling pathways.” These are chains of proteins that pass signals inside cells.
Polyclonal antibodies can detect proteins in these pathways, such as AKT, MAPK, and mTOR. When researchers find these proteins are too active, it shows which signals are driving the tumor.
By studying these patterns, scientists can test drugs that block these signals. This leads to new treatment options for patients.
The Bottom Line
Polyclonal antibodies are powerful tools for GIST research. They help find tumor markers, confirm mutations, and study growth signals. This makes diagnosis and treatment more accurate. However, make sure you buy polyclonal antibodies online from a reliable source to support research and medical studies.
